705 Participants NeededMy employer runs this trial

JNJ-99245354 for Anxiety

Recruiting at 3 trial locations
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Intra-Cellular Therapies, Inc.
Stay on Your Current MedsYou can continue your current medications while participating
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to assess if JNJ-99245354 administered once daily works better to reduce anxiety compared to placebo when given as an additional (adjunctive) therapy in participants with generalized anxiety disorder (GAD; a mental health condition defined by uncontrollable, and excessive worry about everyday events for a long period of time).

Who Is on the Research Team?

IT

Intra-Cellular Therapies, Inc. Clinical Trial

Principal Investigator

Intra-Cellular Therapies, Inc.

Are You a Good Fit for This Trial?

This trial is for adults with generalized anxiety disorder who still have symptoms despite trying at least one approved anxiety treatment. Participants must be medically stable, have a BMI between 19 and 40, and be able to stay as outpatients during the study.

Inclusion Criteria

I am currently an outpatient and expect to stay that way during the trial.
My BMI is between 19 and 40.
I have tried at least one approved GAD treatment that did not work for me.
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • JNJ-99245354

Trial Overview

The study tests whether adding JNJ-99245354 (taken once daily) helps reduce anxiety more than a placebo when used alongside current treatments in people with GAD. Participants are randomly assigned to receive either the new drug or placebo.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Placebo Group

Group I: JNJ-99245354: Dose 2Experimental Treatment1 Intervention
Group II: JNJ-99245354: Dose 1Experimental Treatment1 Intervention
Group III: PlaceboPlacebo Group2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Intra-Cellular Therapies, Inc.

Lead Sponsor

Trials
42
Recruited
10,700+